cardiac

(redirected from cardiac hypertrophy)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to cardiac hypertrophy: myocardial hypertrophy

car·di·ac

 (kär′dē-ăk′)
adj.
1. Of, near, or relating to the heart: cardiac arteries. See Usage Note at coronary.
2. Of or relating to the cardia.
n.
A person with a heart disorder.

[Middle English, from Latin cardiacus, from Greek kardiakos, from kardiā, heart; see kerd- in Indo-European roots.]

cardiac

(ˈkɑːdɪˌæk)
adj
1. (Anatomy) of or relating to the heart
2. (Anatomy) of or relating to the portion of the stomach connected to the oesophagus
n
3. (Medicine) a person with a heart disorder
4. (Pharmacology) obsolete a drug that stimulates the heart muscle
[C17: from Latin cardiacus, from Greek, from kardia heart]

car•di•ac

(ˈkɑr diˌæk)

adj.
1. of or pertaining to the heart: cardiac disease.
2. of or pertaining to the esophageal portion of the stomach.
n.
3. a person suffering from heart disease.
[1400–50; late Middle English (< Middle French cardiaque) < Latin cardiacus < Greek kardiakós <kardí(a) heart]

car·di·ac

(kär′dē-ăk′)
Relating to the heart: a cardiac disorder.

cardiac

Relating to the heart.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.cardiac - of or relating to the heart; "cardiac arrest"
Translations
قَلْبي، مُتَعَلِّقٌ بالقَلب
srdeční
hjerte-
قلبی
szív-
hjarta-
širdies
sirds-
kalbe ait

cardiac

[ˈkɑːdɪæk]
A. ADJcardíaco
B. CPD cardiac arrest Nparo m cardíaco

cardiac

[ˈkɑːrdiæk] adjcardiaquecardiac arrest narrêt m cardiaque

cardiac

adjHerz-

cardiac

[ˈkɑːdɪæk] adj (Med) → cardiaco/a

cardiac

(ˈkaːdiӕk) adjective
of the heart. This patient has a cardiac complaint; cardiac failure.

car·di·ac

a. cardíaco-a, referente al corazón.

cardiac

adj cardíaco or cardiaco
References in periodicals archive ?
Independent of the mothers' diet components, adult female offspring exposed to maternal androgens in utero developed pathological cardiac hypertrophy, which was linked to early cardiac remodeling.
Cardiac hypertrophy (CH) is a compensatory response in the heart induced by various physiological or pathological stimuli.
Furthermore, it may cause cardiac hypertrophy and hypertension by regulating cytokines and oxidative stress (7).
Moreover, in cardiac hypertrophy NT-proBNP is considered a discerning marker.
Prolonged cardiac hypertrophy may lead to heart failure, but little is known about the role of miR-24 in cardiac hypertrophy.
It concluded that inhibition of xanthine oxidase by oxypurinol in heart failure patients improved left ventricle ejection fraction (LVEF) in patients with LVEF less than or equal to 40% after 1 month of treatment.24 The findings in the current study are parallel with the results of the cited trial24 and means that the reduction in reactive oxygen species with allopurinol can have favourable effects on cardiac hypertrophy without the requirement of reducing blood pressure.
A pharmacological study performed in a rat model demonstrated that PXL770 administration (75 mg/kg bid) did not induce cardiac hypertrophy after 16 weeks of treatment in toxicological studies and no adverse effects of cardiac hypertrophy or accumulation of glycogen in the myocardium were detected at 1000 mg/kg dosing during 13 weeks of PXL770 treatment.
According to research from www.verywellfit.com, clenbuterol may cause cardiac hypertrophy or the enlargement of heart venticles, a potentially serious form of heart damage as well as irregular, heart rhythms.
Leading causes of death were coronary disease (32 percent), occult overdose (13.5 percent), cardiomyopathy (10 percent), cardiac hypertrophy (8 percent), and neurological (5.5 percent).
(3) Although there is a need for more substantiation and current evidence is mostly anecdotal, emerging consensus supports an association of AAS abuse with an increased risk of sudden cardiac death, myocardial infarction, abnormal lipid profile, and cardiac hypertrophy. (4) Cardiovascular responses to AAS are due to certain myocardial receptors that have transcriptional regulatory functions.
stated that "progressive increase in duration of QT interval associated with the development of cardiac hypertrophy and hypertension not directly related to the increased left ventricular weight which has been documented in spontaneous hypertensive rats." [10] Baumert et al.